Global Pandemic Influenza Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 21-Sep-2018
No. of pages: 122

Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.

Scope of the Report:

This report focuses on the Pandemic Influenza Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Pandemic Influenza Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- AstraZeneca

- GlaxoSmithKline

- Novartis

- Sanofi

- Valneva

- Lupin

- Chiron Panacea

- Solvay and Serum Institute of India Pvt. Ltd.

- Sementis

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Influenza A (H1N1) Vaccines

- Other

Market Segment by Applications, can be divided into

- Adult

- Paediatric

There are 15 Chapters to deeply display the global Pandemic Influenza Vaccine market.

Chapter 1, to describe Pandemic Influenza Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pandemic Influenza Vaccine, with sales, revenue, and price of Pandemic Influenza Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pandemic Influenza Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Pandemic Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Pandemic Influenza Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Pandemic Influenza Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Pandemic Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Influenza A (H1N1) Vaccines
1.2.2 Other
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Paediatric
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Pandemic Influenza Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Pandemic Influenza Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Pandemic Influenza Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Pandemic Influenza Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valneva
2.5.1 Business Overview
2.5.2 Pandemic Influenza Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valneva Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lupin
2.6.1 Business Overview
2.6.2 Pandemic Influenza Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Chiron Panacea
2.7.1 Business Overview
2.7.2 Pandemic Influenza Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Solvay and Serum Institute of India Pvt. Ltd.
2.8.1 Business Overview
2.8.2 Pandemic Influenza Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sementis
2.9.1 Business Overview
2.9.2 Pandemic Influenza Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sementis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pandemic Influenza Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pandemic Influenza Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pandemic Influenza Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Pandemic Influenza Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pandemic Influenza Vaccine Market Analysis by Regions
4.1 Global Pandemic Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pandemic Influenza Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
5 North America Pandemic Influenza Vaccine by Countries
5.1 North America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6 Europe Pandemic Influenza Vaccine by Countries
6.1 Europe Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.4 France Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pandemic Influenza Vaccine by Countries
7.1 Asia-Pacific Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.5 India Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
8 South America Pandemic Influenza Vaccine by Countries
8.1 South America Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pandemic Influenza Vaccine by Countries
9.1 Middle East and Africa Pandemic Influenza Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
10 Global Pandemic Influenza Vaccine Market Segment by Type
10.1 Global Pandemic Influenza Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pandemic Influenza Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Influenza A (H1N1) Vaccines Sales Growth and Price
10.2.1 Global Influenza A (H1N1) Vaccines Sales Growth (2013-2018)
10.2.2 Global Influenza A (H1N1) Vaccines Price (2013-2018)
10.3 Other Sales Growth and Price
10.3.1 Global Other Sales Growth (2013-2018)
10.3.2 Global Other Price (2013-2018)
11 Global Pandemic Influenza Vaccine Market Segment by Application
11.1 Global Pandemic Influenza Vaccine Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Paediatric Sales Growth (2013-2018)
12 Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.1 Global Pandemic Influenza Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Pandemic Influenza Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.2 Europe Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.4 South America Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pandemic Influenza Vaccine Market Forecast (2018-2023)
12.3 Pandemic Influenza Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Pandemic Influenza Vaccine Market Share Forecast by Type (2018-2023)
12.4 Pandemic Influenza Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Pandemic Influenza Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pandemic Influenza Vaccine Picture
Table Product Specifications of Pandemic Influenza Vaccine
Figure Global Sales Market Share of Pandemic Influenza Vaccine by Types in 2017
Table Pandemic Influenza Vaccine Types for Major Manufacturers
Figure Influenza A (H1N1) Vaccines Picture
Figure Other Picture
Figure Pandemic Influenza Vaccine Sales Market Share by Applications in 2017
Figure Adult Picture
Figure Paediatric Picture
Figure United States Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pandemic Influenza Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Pandemic Influenza Vaccine Type and Applications
Table AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Pandemic Influenza Vaccine Type and Applications
Table GlaxoSmithKline Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Pandemic Influenza Vaccine Type and Applications
Table Novartis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Pandemic Influenza Vaccine Type and Applications
Table Sanofi Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valneva Basic Information, Manufacturing Base and Competitors
Table Valneva Pandemic Influenza Vaccine Type and Applications
Table Valneva Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Pandemic Influenza Vaccine Type and Applications
Table Lupin Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chiron Panacea Basic Information, Manufacturing Base and Competitors
Table Chiron Panacea Pandemic Influenza Vaccine Type and Applications
Table Chiron Panacea Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Solvay and Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Type and Applications
Table Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sementis Basic Information, Manufacturing Base and Competitors
Table Sementis Pandemic Influenza Vaccine Type and Applications
Table Sementis Pandemic Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Pandemic Influenza Vaccine Sales by Manufacturer (2016-2017)
Figure Global Pandemic Influenza Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Pandemic Influenza Vaccine Sales Market Share by Manufacturer in 2017
Table Global Pandemic Influenza Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Pandemic Influenza Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pandemic Influenza Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Global Pandemic Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table Global Pandemic Influenza Vaccine Sales by Regions (2013-2018)
Table Global Pandemic Influenza Vaccine Sales Market Share by Regions (2013-2018)
Table Global Pandemic Influenza Vaccine Revenue by Regions (2013-2018)
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Regions in 2013
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Regions in 2017
Figure North America Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure North America Pandemic Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table North America Pandemic Influenza Vaccine Sales by Countries (2013-2018)
Table North America Pandemic Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Pandemic Influenza Vaccine Sales Market Share by Countries in 2013
Figure North America Pandemic Influenza Vaccine Sales Market Share by Countries in 2017
Table North America Pandemic Influenza Vaccine Revenue by Countries (2013-2018)
Table North America Pandemic Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Pandemic Influenza Vaccine Revenue Market Share by Countries in 2013
Figure North America Pandemic Influenza Vaccine Revenue Market Share by Countries in 2017
Figure United States Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pandemic Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Pandemic Influenza Vaccine Sales by Countries (2013-2018)
Table Europe Pandemic Influenza Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Pandemic Influenza Vaccine Revenue by Countries (2013-2018)
Figure Europe Pandemic Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Europe Pandemic Influenza Vaccine Revenue Market Share by Countries in 2017
Figure Germany Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure UK Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure France Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pandemic Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pandemic Influenza Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pandemic Influenza Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Pandemic Influenza Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Pandemic Influenza Vaccine Revenue Market Share by Countries 2017
Figure China Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure India Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pandemic Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table South America Pandemic Influenza Vaccine Sales by Countries (2013-2018)
Table South America Pandemic Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Pandemic Influenza Vaccine Sales Market Share by Countries in 2017
Table South America Pandemic Influenza Vaccine Revenue by Countries (2013-2018)
Table South America Pandemic Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Pandemic Influenza Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pandemic Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pandemic Influenza Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Pandemic Influenza Vaccine Sales and Growth Rate (2013-2018)
Table Global Pandemic Influenza Vaccine Sales by Type (2013-2018)
Table Global Pandemic Influenza Vaccine Sales Share by Type (2013-2018)
Table Global Pandemic Influenza Vaccine Revenue by Type (2013-2018)
Table Global Pandemic Influenza Vaccine Revenue Share by Type (2013-2018)
Figure Global Influenza A (H1N1) Vaccines Sales Growth (2013-2018)
Figure Global Influenza A (H1N1) Vaccines Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Pandemic Influenza Vaccine Sales by Application (2013-2018)
Table Global Pandemic Influenza Vaccine Sales Share by Application (2013-2018)
Figure Global Paediatric Sales Growth (2013-2018)
Figure Global Pandemic Influenza Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Pandemic Influenza Vaccine Sales Forecast by Regions (2018-2023)
Table Global Pandemic Influenza Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Pandemic Influenza Vaccine Market Forecast (2018-2023)
Figure Europe Sales Pandemic Influenza Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Pandemic Influenza Vaccine Market Forecast (2018-2023)
Figure South America Sales Pandemic Influenza Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Pandemic Influenza Vaccine Market Forecast (2018-2023)
Table Global Pandemic Influenza Vaccine Sales Forecast by Type (2018-2023)
Table Global Pandemic Influenza Vaccine Market Share Forecast by Type (2018-2023)
Table Global Pandemic Influenza Vaccine Sales Forecast by Application (2018-2023)
Table Global Pandemic Influenza Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Global Calming and Sleeping Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. Scope of the Report: This report focuses on the Calming and Sleeping in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. They are used to tr......
  • Global Compound Clotrimazole Ointment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Compound clotrimazole is a broad spectrum anti-fungal agent, which is used for the treatment of dermal infections. The ointment is majorly used for the topical treatment of candidiasis and tinea versicolor pityriasis versicolor. In addition, it is used in the treatment of dermal infections such as Athletes foot, crotch itch, and ringworm. Scope of the Report: This report focuses on the Compound Clotrimazole Ointment in global market, especially in North America, Eur......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3CA or PIK3CA or EC 2.7.11.1 or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 98
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3CA or PIK3CA or EC 2.7.11.1 or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary According to the recently published report 'Phosphatidylinositol 4,5 Bisphosphate 3 Kinase - Pipeline Review, H2 2018'; Phosphatidylino......
  • Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 80
    Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018 Summary According to the recently published report 'Caspase 3 - Pipeline Review, H2 2018'; Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to 13 molecules. Out of which approximately 9 molecules are developed by companies a......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis 2013-2018 and Forecast 2019-2025
    Published: 16-Oct-2018        Price: US 2900 Onwards        Pages: 133
    This report studies the Chemotherapy Induced Peripheral Neuropathy Treatment market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Chemotherapy Induced Peripheral Neuropathy Treatment market by product type and applications/end industries. In the last several years, global market of Chemotherapy Induced Peripheral Neuropathy Treatment......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs